New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV). Agreement between FA and spectral domain OCT in detecting the activity of myopic subfoveal CNV
Choroidal neovascularization management in pathological myopia / Alessandro Papayannis - Udine. , 2012 May 19. 24. ciclo
Choroidal neovascularization management in pathological myopia
PAPAYANNIS, Alessandro
2012-05-19
Abstract
New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV). Agreement between FA and spectral domain OCT in detecting the activity of myopic subfoveal CNVFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
10990_155_Management of mCNV A Papayannis pdf A.pdf
accesso aperto
Tipologia:
Tesi di dottorato
Licenza:
Non specificato
Dimensione
1.46 MB
Formato
Adobe PDF
|
1.46 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.